Related Experiment Video
Updated: Aug 6, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
The main causes of death in patients with COVID-19
P Oboza1, N Ogarek, M Olszanecka-Glinianowicz
1Students' Scientific Society at the Pathophysiology Unit, Pathophysiology Unit, Health Promotion and Obesity Management Unit, Department of Pathophysiology, Medical Faculty, The Medical University of Silesia, Katowice, Poland. pkocelak@sum.edu.pl.
Insights
The primary cause of COVID-19 deaths is multiple organ failure, driven by severe inflammation and genetic factors. Thrombotic microangiopathy, particularly in microcirculation, emerges as a dominant, fatal mechanism in COVID-19 mortality.
Area of Science:
- * Pathology and Public Health
- * Infectious Diseases and Epidemiology
Background:
- * The COVID-19 pandemic has caused millions of deaths globally, with significant mortality reported in the United States, Brazil, and India.
- * Understanding the precise mechanisms leading to fatal outcomes in COVID-19 is crucial for effective treatment and prevention strategies.
Purpose of the Study:
- * To analyze available data on the causes of death attributed to COVID-19.
- * To identify the primary pathological mechanisms underlying COVID-19 mortality.
Main Methods:
- * Retrospective analysis of reported COVID-19 mortality data.
- * Review of scientific literature on COVID-19 pathological mechanisms and contributing factors.
Main Results:
- * Multiple organ failure is identified as the primary cause of death from COVID-19.
- * Severe inflammatory response, potentially influenced by genetic predisposition, contributes significantly to organ failure.
- * Systemic thrombotic microangiopathy and lung inflammation leading to hypoxia are key pathological processes, with thrombotic changes in microcirculation being the most dominant factor.
Conclusions:
- * COVID-19 mortality is predominantly linked to multiple organ failure resulting from complex pathological pathways.
- * Thrombotic microangiopathy and severe inflammation are critical determinants of fatal COVID-19 outcomes.
- * Comorbidities may exacerbate thrombotic risks in COVID-19 patients, highlighting the multifaceted nature of the disease's lethality.
Abstract:
By March 21, 2022, 6.1 million deaths from COVID-19 were reported, most of them in the United States, Brazil, and India. Between January 1, 2020, and December 31, 2021, the global estimated mortality due to the COVID-19 pandemic was 120.3 deaths (113.1-129.3) per 100,000 of the population for all ages. So far, many of the potentially fatal mechanisms of COVID-19 have been reported. In this manuscript, we analyzed the available data on the causes of deaths from COVID-19. This analysis suggests that the primary attributable cause of death from COVID-19 is multiple organ failure resulting from numerous pathological mechanisms, including genetic predisposition to the severe inflammatory response. Increased inflammatory response affects the lungs locally as well as systemic thrombotic microangiopathy. It seems that many comorbidities associated with an increased mortality rate among patients with COVID-19 per se predispose them to an increased risk of thrombotic changes. Furthermore, the role of inflammation in the lungs and the changes that lead to hypoxia cannot be overlooked. However, the thrombotic changes in microcirculation seem to be the most dominant.
More Related Videos
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Acute Respiratory Failure-III
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...

